Skip to content

Evolent Health, Inc. EVH Net Change in Cash

Net Change in Cash at other companies

CVS Health logo
CVS HealthCVS
$1.06B-27.7%
UnitedHealth Group logo
UnitedHealth GroupUNH
$3.64B-32.7%
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
-$3.29M+66.9%
Astrana Health logo
Astrana HealthASTH
$49.25M+265%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$800.32M+9,394%
Elevance Health logo
Elevance HealthELV
$166M+121%

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s net change in cash?
Evolent Health, Inc. (EVH) reported net change in cash of -$11.95M in Q1 2026.
How has Evolent Health, Inc.'s net change in cash changed year-over-year?
Evolent Health, Inc.'s net change in cash decreased by 112.0% year-over-year, from $99.35M to -$11.95M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.